Audit Information	12 Months Ended
Dec. 31, 2025
Auditor [Line Items]
Auditor Name	WithumSmith+Brown, PC
Auditor Firm ID	100
Auditor Location	Whippany, New Jersey
Auditor Opinion [Text Block]	Opinion on the consolidated financial statements We have audited the accompanying consolidated balance sheets of Turn Therapeutics, Inc. (formerly, “Global Health Solutions Inc.”) (the “Company”) as of December 31, 2025 and 2024, and the related consolidated statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the two years ended December 31, 2025 and 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the two years ended December 31, 2025 and 2024, in conformity with principles generally accepted in the United States of America.

100

Opinion on the consolidated financial statements

We have audited the accompanying consolidated balance sheets of Turn Therapeutics, Inc. (formerly, “Global Health Solutions Inc.”) (the “Company”) as of December 31, 2025 and 2024, and the related consolidated statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the two years ended December 31, 2025 and 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the two years ended December 31, 2025 and 2024, in conformity with principles generally accepted in the United States of America.